Member Info for Terrier54

Yes SPAC were given a tempting transfer price so the fact that this is now hovering around it is a great investment entry.

A dip back but fundamentals here are rock solid.
Next bull run on the way imo.

Settling nicely.
A few thinly veiled de-rampers surfacing lol
Always a good sign.
Quality will prevail from this exciting opportunity.

Quick look in while Gasly's car removed in Practice 2.
There's our seller , fair play can't fault taking a bit of profit.
Looking very healthy.
All set to break into 140-150p

Excellent résumé sunnyca of what is ahead.
The possibility of a sudden placing is now on the backburner and it gives time for 4D to report on its next news which could make this look ridiculously cheap.
Nothings a certainty but this Bod is ticking all the right boxes atm.
Exciting times indeed.

Just checking the SP after arriving at Portimao for F1.
Good to see the market has responded as it should.
This is just the start.
GLE

Thanks for the info yesterday Trendz, my top up at 89p hit the spot.
Regards Terrier.

https://twitter.com/4dpharmaplc/status/1319162353380974592?s=19

After the SP climbed to 180p recently know wonder Longevity are happy with 110p !
Big days ahead for those that look a bit further than a few hours.
My biggest investment by far.

Look back 2 years from now and I believe you'll wished you bought more.

Axel Glasmacher, Non-Executive Chairperson of 4D pharma, commented: "2020 has undeniably been a defining period for the Live Biotherapeutics field, and 4D pharma has continued building its leading position. We announced proof-of-concept efficacy data in oncology for lead candidate MRx0518, and have made meaningful progress in other important therapeutic areas. In concert with this growth, 4D has further expanded both its leadership expertise and its international shareholder base. 4D pharma now looks ahead to the remainder of 2020 and beyond, as we continue to deliver clinical data and pioneer this rapidly developing new area of medicine."

Over 3 million in 25 minutes !
Climb aboard.

Release the beast !

Commenting on the Merger, Matthew Chen, Chief Executive Officer of Longevity said: "We are truly excited about the Merger with 4D. Our team reviewed many opportunities in a variety of industries, and determined that the Transaction with 4D would provide the greatest value to our shareholders. 4D is developing promising biotherapeutics to address unmet medical needs. We are impressed by 4D management team's track record in drug development and partnership building. We are very excited about the future prospects of the Enlarged Group."

I did say yesterday that when someone said 'no news for a while' that was impossible to predict !
This is the step needed to turn this company into a mid-tier pharma within 2 years.
Amazing and just shows what respect 4D has now with it's proven research.
No funding issue for ages so watch this rapidly move up now !
They kept that news quiet !
Well done lth's

"The commercial opportunity provided by Blautix® could be substantial, given the need for a safe and effective treatment across IBS-C and IBS-D populations"

Big reversal ?

Looks like some heavy chunks buying absorbing the sells...

Sale.
180 to 90p on an RNS stating it's going to Phase 3.

rob Saunders

You have absolutely no idea that 'no news coming' unless you sit in the CEO's office and even then things can happen without them.How about a Merck increase in holding at this level ? Maybe it's being worked.

Shorts will close